INMUNE BIO INC (INMB) Stock Earnings & Estimates
NASDAQ:INMB - US45782T1051 - Common Stock
2.09 USD
+0.04 (+2.2%)
2.1 USD
+0.01 (+0.48%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 370K 105.56% | 155K -58.11% | 14K -90.97% | 33.997K 142.83% | 5.059M 14,780.90% | 10.315M 103.89% | 27.037M 162.11% | 74.852M 176.85% | 157.05M 109.81% | 271.08M 72.61% | 408.19M 50.58% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -25.95M 10.98% | -30M -15.61% | -43M -43.33% | -40.845M 5.01% | -43.386M -6.22% | -46.709M -7.66% | -33.486M 28.31% | 1.104M 103.30% | 50.355M 4,461.14% | 113.66M 125.72% | 167.45M 47.33% | |
| Operating Margin | -7,013.51% | -19,354.84% | -307,142.86% | -120,144.43% | -857.60% | -452.82% | -123.85% | 1.47% | 32.06% | 41.93% | 41.02% | |
| EPS YoY % growth | -1.52 18.28% | -1.67 -9.87% | -2.11 -26.35% | -1.50 29.06% | -1.54 -3.12% | -1.30 15.75% | -0.80 38.82% | 0.13 116.67% | 1.40 957.69% | 3.06 118.18% | 4.49 46.67% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.34 42.77% | -0.35 13.30% | -0.33 22.67% | -0.32 69.11% | -0.35 -0.99% | -0.37 -5.88% |
| Revenue Q2Q % growth | 1.129M 2,158.00% | 1.178M | 1.915M | 1.988M | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.98M 25.17% | -9.351M 1.26% | -8.437M 14.87% | -8.255M -3.18% | -7.876M 12.29% | -7.903M 15.48% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.05 -110.00% | -0.39 | -0.66 | -169.71% |
| Q1 2025 Q2Q % growth | -0.43 29.51% | -0.48 | 0.05 | 10.30% |
| Q4 2024 Q2Q % growth | -0.40 14.89% | -0.55 | 0.15 | 27.38% |
| Q3 2024 Q2Q % growth | -0.60 -25.00% | -0.51 | -0.09 | -18.44% |
| Q2 2024 Q2Q % growth | -0.50 -38.89% | -0.64 | 0.14 | 22.19% |
| Q1 2024 Q2Q % growth | -0.61 -69.44% | -0.55 | -0.06 | -11.78% |
| Q4 2023 Q2Q % growth | -0.47 -46.87% | -0.45 | -0.02 | -4.72% |
| Q3 2023 Q2Q % growth | -0.48 -11.63% | -0.40 | -0.08 | -19.14% |
| Q2 2023 Q2Q % growth | -0.36 5.26% | -0.40 | 0.04 | 11.02% |
| Q1 2023 Q2Q % growth | -0.36 7.69% | -0.02 | -0.34 | -1,664.71% |
| Q4 2022 Q2Q % growth | -0.32 41.82% | -0.49 | 0.17 | 35.31% |
| Q3 2022 Q2Q % growth | -0.43 21.82% | -0.54 | 0.11 | 19.70% |
| Q2 2022 Q2Q % growth | -0.38 13.64% | -0.52 | 0.14 | 26.23% |
| Q1 2022 Q2Q % growth | -0.39 -21.88% | -0.65 | 0.26 | 40.26% |
| Q4 2021 Q2Q % growth | -0.55 -111.54% | -0.59 | 0.04 | 6.49% |
| Q3 2021 Q2Q % growth | -0.55 -52.78% | -0.36 | -0.19 | -51.89% |
| Q2 2021 Q2Q % growth | -0.44 -120.00% | -0.35 | -0.09 | -26.87% |
| Q1 2021 Q2Q % growth | -0.32 -68.42% | -0.28 | -0.04 | -14.78% |
| Q4 2020 Q2Q % growth | -0.26 -18.18% | -0.31 | 0.05 | 17.11% |
| Q3 2020 Q2Q % growth | -0.36 -28.57% | -0.17 | -0.19 | -111.76% |
| Q2 2020 Q2Q % growth | -0.20 -5.26% | -0.20 | 0.00 | 1.96% |
| Q1 2020 Q2Q % growth | -0.19 5.00% | -0.21 | 0.02 | 11.30% |
| Q4 2019 Q2Q % growth | -0.22 | -0.26 | 0.04 | 13.73% |
| Q3 2019 Q2Q % growth | -0.28 | -0.20 | -0.08 | -41.99% |
| Q2 2019 Q2Q % growth | -0.19 | -0.19 | 0.00 | 1.96% |
| Q1 2019 Q2Q % growth | -0.20 | -0.19 | -0.01 | -3.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.703K | -1.703K | -100.00% | |
| Q1 2025 Q2Q % growth | 50K 257.14% | 50K | % | |
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2024 Q2Q % growth | -100.00% | % | ||
| Q2 2024 Q2Q % growth | -100.00% | 3.397K | -3.397K | -100.00% |
| Q1 2024 Q2Q % growth | 14K -65.00% | 30.6K | -16.6K | -54.25% |
| Q4 2023 Q2Q % growth | 28K -72.00% | 43.86K | -15.86K | -36.16% |
| Q3 2023 Q2Q % growth | 43K -57.00% | 43K | % | |
| Q2 2023 Q2Q % growth | 46K 130.00% | 46K | % | |
| Q1 2023 Q2Q % growth | 40K -75.00% | % | ||
| Q4 2022 Q2Q % growth | 100K -37.50% | 100K | % | |
| Q3 2022 Q2Q % growth | 100K 900.00% | 100K | % | |
| Q4 2021 Q2Q % growth | 160K 1,500.00% | 160K | % | |
| Q3 2021 Q2Q % growth | 10K | 1.479M | -1.469M | -99.32% |
| Q2 2019 Q2Q % growth | 85.17K | -85.17K | -100.00% | |
| Q1 2019 Q2Q % growth | 170.34K | -170.34K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.91% | 24.17% | 5.63% | 15.85% |
| Revenue | -100% | N/A | -20.01% | 166.64% |